Capecitabine: all 1,069 studies that test it
Page 8 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast CancerStatus unknownNCT01501669Phase 3
- Capecitabine in the Perioperative Treatment of Rectal CancerCompletedNCT01500993Phase 3
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersCompletedNCT01497392Phase 1
- A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal CancerCompletedNCT01472770Phase 2
- Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
- Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric JunctionStatus unknownNCT01468389Phase 3
- Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and RadiotherapyCompletedNCT01434147Phase 2
- Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast CancerCompletedNCT01433614Phase 3
- AX Versus AC as Adjuvant Treatment for Node-Negative Breast CancerStatus unknownNCT01415336Phase 2/3
- XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric CancerStatus unknownNCT01412294Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast CancerCompletedNCT01387373Phase 2
- Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)CompletedNCT01380808Phase 2
- A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerCompletedNCT01364493Phase 2
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3
- Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric AdenocarcinomaTerminatedNCT01351038Phase 2
- Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT01349088Phase 1/2
- Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas CancerStatus unknownNCT01333332Phase 2
- Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric CancerStatus unknownNCT01331928Phase 2
- Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal CancerCompletedNCT01322152Phase 2
- A Study of Tesetaxel Plus Capecitabine in Patients With Solid TumorsStatus unknownNCT01315431Phase 1
- Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal CancerCompletedNCT01308190Phase 3
- Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerStatus unknownNCT01308086Phase 3
- A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerCompletedNCT01304784Phase 1
- Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01303029Phase 2
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasCompletedNCT01298401Phase 1
- Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicable
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal CancerCompletedNCT01273051Phase 2
- Neoadjuvant FDR GX in Locally Advanced Pancreatic CancerCompletedNCT01268384Phase 2
- Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.CompletedNCT01262469Phase 2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaCompletedNCT01247337Phase 2
- Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNCT01245582Phase 3
- Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerTerminatedNCT01238029Phase 1
- ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT01234324Phase 2
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.CompletedNCT01229813Phase 3
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
- Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
- Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the BreastCompletedNCT01204437Phase 2/3
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedNCT01200212Phase 3
- Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast CancerStatus unknownNCT01196455Phase 2
- Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and IIIStatus unknownNCT01196260Phase 2/3
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) PatientsCompletedNCT01182142Phase 2
- Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisStatus unknownNCT01167049Phase 2
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal CancerCompletedNCT01152710Phase 2
- Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic CancerCompletedNCT01150630Phase 2
- Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal CancerTerminatedNCT01145404Phase 2
- Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
- Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast CancerCompletedNCT01112826Phase 3
- A Trial of RAD001/Capecitabine in Refractory Gastric CancerCompletedNCT01099527Phase 1/2
- Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal CancerCompletedNCT01080547Phase 3
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) ProgressionCompletedNCT01077726Phase 2
- Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerTerminatedNCT01069796Phase 2
- Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerTerminatedNCT01067989Phase 2
- Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
- A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerStatus unknownNCT01064999Phase 2/3
- Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal CancerActive, not recruitingNCT01061515Phase 1
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced CancerCompletedNCT01050985Phase 1
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Study of Perifosine + Capecitabine for Colon Cancer PatientsCompletedNCT01048580Phase 1
- Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal CancerCompletedNCT01043484Phase 2
- Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01032057Phase 2
- Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
- Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
- Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWithdrawnNCT01017822Phase 1/2
- Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)Status unknownNCT00997685Phase 2
- Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerStatus unknownNCT00985556Phase 2
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
- Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXPCompletedNCT00976976Phase 2
- Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)CompletedNCT00973609Phase 3
- Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00972881Phase 1/2
- Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal CancerStatus unknownNCT00967655Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00962312Phase 2
- Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug MetabolismWithdrawnNCT00960544Phase 2
- Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer PatientsCompletedNCT00960349Phase 1
- Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal CancerWithdrawnNCT00954876Phase 2
- Predicting Response to Capecitabine in Women With Metastatic Breast CancerCompletedNCT00953537Not applicable
- A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerCompletedNCT00952497Phase 2
- Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal CancerTerminatedNCT00950820Phase 2
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer RectumCompletedNCT00909987Phase 2
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal AdenocarcinomasCompletedNCT00909402Phase 1
- Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal CancerCompletedNCT00905047Phase 3
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaStatus unknownNCT00881816Phase 1
- Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsCompletedNCT00875771Phase 2
- Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer PatientsCompletedNCT00873353Phase 2
- Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach AdenocarcinomaTerminatedNCT00871273Phase 4
- External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00869570Phase 1/2
- Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerStatus unknownNCT00865982Phase 2
- Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver MetastasesCompletedNCT00858429Phase 1